Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

15.68
Delayed Data
As of Apr 29
 -0.46 / -2.85%
Today’s Change
9.16
Today|||52-Week Range
17.55
-6.94%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close16.14
Today’s open16.04
Day’s range15.49 - 16.13
Volume935,342
Average volume (3 months)1,617,239
Market cap$2.2B
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-62.06%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book339.65

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...-0.56-1.15%
DBVTDBV Technologies SA-0.31-0.90%
LXRXLexicon Pharmaceutic...-0.15-1.07%
PRAHPRA Health Sciences ...-1.17-2.41%
Data as of 04/29/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs